Alto Neuroscience, Inc. (ANRO)
18.30
+0.68
(+3.86%)
USD |
NYSE |
Feb 23, 16:00
18.31
+0.01
(+0.05%)
Pre-Market: 19:59
Alto Neuroscience Shareholders Equity (Quarterly) : 111.56M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 48.81M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Fortress Biotech, Inc. | 55.86M |
| Oramed Pharmaceuticals, Inc. | 203.28M |
| Replimune Group, Inc. | 210.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 147.01M |
| Total Liabilities (Quarterly) | 35.45M |
| Debt to Equity Ratio | 0.2467 |
| Current Ratio | 15.42 |
| Net Debt Paydown Yield | -3.20% |